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In signal-recognition particle (SRP)-dependent protein targeting to
the bacterial plasma membrane, two GTPases, Ffh (a subunit of the
bacterial SRP) and FtsY (the bacterial SRP receptor), act as GTPase
activating proteins for one another. The molecular mechanism of
this reciprocal GTPase activation is poorly understood. In this work,
we show that, unlike other GTPases, free FtsY exhibits only low
preference for GTP over other nucleotides. On formation of the
SRPFtsY complex, however, the nucleotide specificity of FtsY is
enhanced 103-fold. Thus, interactions with SRP must induce con-
formational changes that directly affect the FtsY GTP-binding site:
in response to SRP binding, FtsY switches from a nonspecific
‘‘open’’ state to a ‘‘closed’’ state that provides discrimination
between cognate and noncognate nucleotides. We propose that
this conformational change leads to more accurate positioning of
the nucleotide and thus could contribute to activation of FtsY’s
GTPase activity by a novel mechanism.
GTPases control a variety of biological processes, includingsignal transduction, translation, vesicle transport, and co-
translational protein targeting. The function of GTPases is
regulated by a GTPase ‘‘switch’’ mechanism, in which the
GTPases undergo conformational changes between an active
GTP-bound form and an inactive GDP-bound form that are
driven by cycles of GTP binding and hydrolysis. For many
GTPases, the rate of interconversion between the active and
inactive forms is modulated by external factors, such as guanine
nucleotide exchange factors, guanine nucleotide dissociation
inhibitors, and GTPase activating proteins (1, 2).
Two interacting GTPases, Ffh and FtsY, mediate cotransla-
tional protein targeting to the bacterial plasma membrane (3).
Ffh and FtsY are homologs of the core components of the
eukaryotic signal-recognition particle (SRP) and SRP receptor,
respectively. Ffh, in complex with a 4.5S RNA, forms a minimal
bacterial SRP that recognizes a nascent polypeptide chain
bearing a signal sequence as it emerges from the ribosome. The
complex of ribosome, nascent chain, and SRP is then targeted to
the plasma membrane via interaction of Ffh with FtsY. On this
interaction, the ribosomenascent chain complex is transferred to
the translocation machinery or ‘‘translocon,’’ which either inte-
grates the protein into or translocates it across the membrane.
Like most GTPases, Ffh and FtsY (and their eukaryotic ho-
mologs) engage in functional cycles that are tightly coupled to
their GTPase cycles (3). During each targeting reaction, GTP
binding is required for complex formation between SRP and
FtsY, allowing the nascent polypeptide chain to be delivered to
the plasma (or endoplasmic reticulum) membrane; subsequent
GTP hydrolysis then drives disassembly of the SRPFtsY com-
plex, allowing the GTPases to be recycled.
The structure of Ffh and FtsY defines them as a unique
subgroup in the GTPase superfamily (4–7). Both proteins
contain a central GTPase domain that shares homology with
other members of the GTPase superfamily, such as Ras and
EF-Tu. On the other hand, all SRP family GTPases also contain
an N-terminal four-helix bundle not present in other GTPases.
The four-helix bundle and the GTPase domain form a structural
and functional unit, called collectively the NG domain (4, 6). In
addition, Ffh and FtsY each possesses a specialized domain that
enables it to play its unique role in protein targeting. FtsY has
an acidic preN domain, or ‘‘A domain,’’ which enables it to
interact with the membrane (8), and Ffh has a C-terminal
methionine-rich domain, or M domain, which contains binding
sites for signal sequences (5, 9–11) and for the SRP RNA (5,
11–13).
The biochemical properties also distinguish Ffh and FtsY from
other classical GTPases. Unlike canonical GTPases that bind
guanine nucleotides tightly and require nucleotide exchange
factors to convert from the GDP- to GTP-bound forms, Ffh and
FtsY have weak nucleotide affinities, with GDP binding and
dissociating quickly (14–16). Therefore, there is no requirement
for nucleotide exchange factors. Further, conversion from their
GTP- to GDP-bound forms is catalyzed by a direct interaction
between Ffh and FtsY, with both proteins acting as GTPase
activating proteins for one another (17). The molecular mech-
anism of this reciprocal GTPase activation remains poorly
understood.
In an attempt to address how the targeting cycle carried out
by Ffh and FtsY is coupled to their GTPase cycles, we probed
their GTPase sites using an FtsY mutant that harbors an Asp3
Asn substitution, FtsY(D449N) (17). This Asp residue, located
in the GTP-binding consensus motif (NTKxD), is conserved
throughout the GTPase superfamily and engages in a hydrogen
bond network with the N2 and N3 amino protons of the guanine
ring (Fig. 1A; refs. 18–21). In many GTPases, mutation of this
Asp residue to Asn weakens their affinity for GTP and strength-
ens their affinity for xanthosine 5-triphosphate (XTP), resulting
in a switch in nucleotide specificity by up to 105-fold (Fig. 1B; see,
e.g., refs. 22–25). Accordingly, we previously showed that, in the
presence of SRP, GTP is hydrolyzed preferentially by wild-type
FtsY, whereas XTP is hydrolyzed preferentially by mutant
FtsY(D449N) (17). Surprisingly, we show here that FtsY ac-
quires nucleotide specificity only on formation of the SRPFtsY
complex. These results provide evidence for conformational
changes in FtsY during interaction with SRP and suggest a novel
mechanism for the activation of FtsY’s GTPase reaction by SRP.
Materials and Methods
Materials. XTP, GTP, and 5-guanylylimidodiphosphate
(GppNHp) were from Sigma and were purified over a
MonoQ column (Amersham Biosciences). Xanthosine 5-
diphosphate and GDP were from Sigma (98%). [-32P]GTP and
[-32P]XTP were from ICN and Amersham Biosciences. A
truncated version of Escherichia coli FtsY, FtsY (47–497), was
used for this study because of its higher solubility and expression
level (26). The expression and purification of Ffh, FtsY, and 4.5S
RNA have been described (26, 27). For arguments against
concerns about GTPase contaminants in FtsY preparations, see
Supporting Text and Fig. 7, which are published as supporting
information on the PNAS web site, www.pnas.org.
Kinetics. All reactions were carried out at 25°C in assay buffer [50
mM KHepes150 mM KOAc2 mM Mg(OAc)22 mM DTT
0.01% Nikkol (Anatrace, Maumee, OH), pH 7.5] with cold GTP
or XTP doped with trace amounts of [-32P]GTP or [-32P]XTP.
This paper was submitted directly (Track II) to the PNAS office.
Abbreviations: SRP, signal-recognition particle; XTP, xanthosine 5-triphosphate; GppNHp,
5-guanylylimido diphosphate; GAP, GTPase-activating protein.
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Reactions were initiated by addition of GTP or XTP and were
followed and analyzed as described (26). Single turnover reac-
tions were followed for 3 half-lives except for very slow
reactions. Good first-order fits to the data, with end points of
90%, were obtained in all cases. For multiple turnover reac-
tions, the initial linear portion of the reaction (20% reaction)
was followed, and an end point of 90% was assumed to obtain
observed rate constants from the initial rates.
Determination of the Basal GTPase and XTPase Activity. The basal
GTPase and XTPase activities of FtsY were measured in single
turnover reactions with FtsY in excess over GTP and XTP,
respectively. The [FtsY] dependence of observed rate constants of
the reaction (kobs) was fit to Eq. 1,
kobs  k0 kc
FtsY
FtsY Km
, [1]
in which kc is the maximal rate constant with saturating FtsY, Km
is the FtsY concentration that gives half the maximal rate
constant, and k0 is a fudge factor that represents the reaction rate
in the absence of FtsY.
Determination of Nucleotide Affinity. The GTP affinity of wild-type
FtsY and mutant FtsY(D449N) was determined from the FtsY
concentration dependence of the basal GTPase reactions according
to Eq. 1. Because the chemical step is rate limiting for the basal
GTPase reaction, Km is equal to Kd, the dissociation constant of
GTP (26). The affinity of other nucleotides was determined by
inhibition methods as described (26).
Determination of Stimulated GTPase and XTPase Reactions. The
SRP-stimulated XTPase reaction of FtsY (XTP*  FtsY 
GTPSRP 3 products) was determined in single turnover experi-
ments with a small fixed amount of FtsY (0.1 M, wild type or
D449N) and varying concentrations of SRP. The SRP-stimulated
GTPase reaction was determined in multiple turnover experiments
in the presence of a small fixed amount of SRP (0.05 M) and
varying concentrations of wild-type FtsY or mutant FtsY(D449N).
The FtsY concentration dependence was fit to single binding curves
analogous to Eq. 1.
Fluorescence Measurements. Fluorescence emission spectra were
acquired as described (26). The association reactions of SRP and
FtsY (wild type and mutant) were carried out in assay buffer in the
presence of 1 M FtsY and 2 M SRP. The spectra for uncom-
plexed FtsY were first determined in the presence of 2 mM EDTA,
and Mg2 was added to a final concentration of 10 mM to initiate
complex formation.
Results
Free FtsY Has Low Nucleotide Specificity. GTPases are generally
characterized by a high degree of specificity toward their nucleotide
substrates. The magnitude of discrimination between cognate and
noncognate bases is typically 102- to 103-fold for well studied
GTPases (see, e.g., refs. 22–25 and 28 and references therein).
We were therefore surprised to find that FtsY shows little
discrimination between nucleotides. As shown in Fig. 2 and sum-
marized in Table 1, FtsY hydrolyzes GTP with a rate constant
(kcKm) of 230 M1 min1, no more than 13-fold faster than the
hydrolysis of noncognate nucleotides such as XTP and ATP.
Similarly, when the binding affinity of cognate nucleotides is
compared with those of noncognate nucleotides (Kds in Table 2),
GTP and GDP bind no more than 30-fold stronger than noncog-
nate nucleotides, including ATP and CTP. This is remarkable,
because it demonstrates that FtsY does not discriminate strongly
even between purine and pyrimidine containing nucleotides.
The nucleotide specificity of GTPases typically arises from a
network of interactions with the guanine base, the most conserved
interaction is the hydrogen bonding network between a conserved
Asp residue in the GTP-binding pocket and the exocyclic amine of
guanine (Fig. 1). In many GTPases, mutation of this Asp residue to
Asn results in a change in the nucleotide preference from GTP to
XTP by up to 105-fold (see, e.g., refs. 22–25 and 28 and references
therein). To probe the contribution of the conserved Asp residue
to the nucleotide specificity of FtsY, we next explored the properties
of FtsY bearing the Asp3Asn mutation, FtsY(D449N). As shown
in Fig. 2 and quantitated in Table 1, mutant FtsY(D449N) hydro-
lyzes XTP only 3-fold faster and GTP only 4-fold slower than
wild-type FtsY, resulting in an indistinguishable rate constant for
Fig. 1. Hydrogen bonding interactions between the base moiety of GTP (G) and
the conserved aspartate residue (A), and between the base moiety of XTP (X) and
a corresponding asparagine residue (B). The Asp-449 residue of FtsY was misla-
beled as Asp-441 in a previous publication (17).
Fig. 2. Basal GTPase (A) and XTPase (B) reactions of wild-type FtsY ( and E)
and mutant FtsY(D449N) ( and F), determined as described in Materials and
Methods. The solid lines are fits of the FtsY concentration dependences to Eq. 1.
For the GTPase reactions (A), the fit gave kc values of 0.0039 and 0.0010 min1
and Km values of 15 and 19 M for FtsY(wt) and FtsY(D449N), respectively.
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GTP and XTP hydrolysis by mutant FtsY(D449N), which is no-
where near the discrimination seen in other GTPases. There are
also 2-fold changes in the nucleotide-binding affinity between
wild-type FtsY and mutant FtsY(D449N) (Table 2). Thus, we
conclude from the data presented so far that free FtsY has a very
low specificity in recognizing different nucleotides and that Asp-449
contributes little, if anything, to the selective recognition of the
cognate nucleotide.
The Presence of SRP Confers Nucleotide Specificity to FtsY. The low
nucleotide specificity of FtsY described above was puzzling in light
of a previous study from this lab, which showed that FtsY and
FtsY(D449N) preferentially hydrolyze their cognate nucleotides
(17). One possible resolution of this paradox was suggested by the
fact that the previous results were obtained in the presence of
bacterial SRP (Ffh bound to 4.5S RNA) and thus measured the
SRP-stimulated reaction, whereas the properties of free FtsY were
examined above. We therefore asked whether SRP modulates the
nucleotide specificity of FtsY.
To test this possibility, we determined the rate constant for XTP
hydrolysis by FtsY and FtsY(D449N) in the presence of increas-
ing amounts of SRP (Fig. 3). The rate constant for the reaction XTP
 FtsY SRP3 products [(kcKm)app
XTP in Table 3], which includes
both binding of SRP to FtsY and SRP-dependent stimulation of
FtsY’s XTPase activity, was compared between wild-type FtsY and
mutant FtsY(D449N). Because SRP also contains a GTPase do-
main that needs to be nucleotide triphosphate-bound to interact
with FtsY, we also added GTP to occupy the GTPase site in SRP.
The concentration of GTP (10 M) was chosen so that the
GTP-binding site in SRP was saturated, whereas that of FtsY was
not. This was possible because GTP binds tighter to SRP than to
FtsY (Kd  0.39 and 15 M for SRP and FtsY, respectively; ref. 26
and Table 2).
The results of this experiment show that XTP hydrolysis by
mutant FtsY(D449N) is stimulated by increasing amounts of SRP
(Fig. 3, filled circles), consistent with the role of SRP as the GTPase
activating protein for FtsY (17, 26). In contrast, wild-type FtsY
shows little enhancement of XTP hydrolysis (open circles) over a
control reaction in which FtsY was omitted (crosses). The rate
constant for XTP hydrolysis with the mutant FtsY(D449N) is 1.6
103-fold faster than with wild-type FtsY [Table 3, (kcKm)rel
XTP]. This
represents a 103-fold discrimination between the cognate and
noncognate nucleotides, comparable to the level of discrimination
typically observed in other GTPases. A similar result was obtained
when the nonhydrolyzable GTP analog, GppNHp, was used instead
of GTP, giving an XTPase rate constant that is 1.1 103-fold faster
with mutant FtsY(D449N) than with wild-type FtsY (not shown).
Thus, the presence of SRP substantially increases the nucleotide
specificity of FtsY, and the amino acid at position 449 (Asp or Asn)
plays a major role in the SRP-induced specificity change.
FtsY Acquires Nucleotide Specificity in the SRPFtsY Complex Forma-
tion Step. The experiment described above showed that FtsY can
discriminate between the cognate and noncognate nucleotides in a
reaction that includes two steps: (i) formation of the SRPFtsY
complex and (ii) stimulation of XTPase activity once the complex
is formed. To determine during which of these two steps FtsY gains
nucleotide specificity, we compared the protein concentration
dependence for the SRP-stimulated GTPase reaction of FtsY when
it is bound to the cognate and noncognate nucleotides. If only
complex formation is impaired when a noncognate nucleotide is
bound to FtsY, then SRP should still be able to substantially
stimulate FtsY’s GTPase activity if complex formation is forced at
high concentrations of FtsY. In contrast, if only the stimulation of
nucleotide hydrolysis by SRP is impaired when a noncognate
nucleotide is bound to FtsY, then no significant stimulation of
Table 1. Basal nucleotide hydrolysis rate constants for wild-type
FtsY and mutant FtsY (D449N)
FtsY construct
kcKm (M1 min1)* GTP specificity†
GTP XTP ATP GTPXTP GTPATP
Wild type 230 17 120 13 1.9
D449N 53 55 58 0.96 0.91
Rel (kwtkD449N) 4.3 0.31 2.1 na na
na, Not applicable.
*The second-order rate constant for the reaction: FtsYNTP3products (kcKm;
N G, X, or A) was determined from the [FtsY] dependence in Fig. 2. For GTP,
this is obtained from the kc and Km values from the fit of data to Eq. 1. For XTP
and ATP, this is obtained from the slope of the initial linear range of the FtsY
concentration dependence (Fig. 2 and data not shown).
†GTP specificity is defined as the preference of the FtsY constructs to hydrolyze
GTP relative to other nucleotides such as XTP and ATP, and was obtained from
the ratio of kcKm values for GTP over XTP or ATP.
Table 2. Nucleotide affinities of wild-type FtsY and mutant
FtsY (D449N)
FtsY construct
Kd, M
GTP GDP GppNHp XTP ITP ATP CTP
Wild type 15 24 38 460 150 250 490
D449N 19 26 24 260 510 670
Fig. 3. SRP preferentially stimulates the XTPase activity of mutant FtsY(D449N).
Observed rate constants for XTP hydrolysis were determined as described in
Materials and Methods with 0.1 M mutant FtsY(D449N) (F) or wild-type FtsY
(E), or with no FtsY added ().
Table 3. Rate constant for SRP-stimulated XTP hydrolysis by
wild-type FtsY and mutant FtsY (D449N)
FtsY construct
(kcKm)appXTP*,
M1 min1
(kcKm)corXTP†,
M1 min1 (kcKm)relXTP‡
D449N 1.5  105 1.5  105 1.6  103
Wild type 270 94 (1)
— 180 (0)
*The apparent second-order rate constant (kcKm)app
XTP was determined from
the slope of the initial linear portion of the SRP concentration dependence
(Fig. 3). The rate constant observed in the absence of FtsY (—) reflects the
slow rate of XTP hydrolysis by SRP.
†The corrected rate constant (kcKm)cor
XTP is the apparent rate constant [(kcKm)app
XTP]
with wild-type FtsY and mutant FtsY (D449N) subtracted by that without added
FtsY. This corrects for the background XTP hydrolysis reaction from SRP.
‡The relative rate constant (kcKm)rel
XTP is the rate constant for XTP hydrolysis
[(kcKm)cor
XTP] by mutant FtsY (D449N) relative to wild-type FtsY.
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FtsY’s GTPase activity would be observed even at high concen-
trations of FtsY.
We therefore determined the rate of GTP hydrolysis in the
presence of a small fixed amount of SRP and varying concentrations
of FtsY or FtsY(D449N) (Fig. 4). The concentration of FtsY,
instead of SRP, was varied because FtsY is much more soluble than
SRP, allowing us to vary its concentration over a wider range. The
concentration of GTP (100 M) in the reaction ensures that the
majority of SRP and FtsY (wild type or mutant) molecules are
bound with GTP. The data show that at low concentration, the
mutant FtsY(D449N) exhibits a lower rate of GTP hydrolysis than
wild-type FtsY (Fig. 4, filled vs. open circles). At high FtsY
concentrations, however, both the mutant and wild-type FtsY
approach similar levels of maximal hydrolysis rate. These results are
thus consistent with the model that efficient complex formation
requires FtsY to be bound to its cognate nucleotide, but once the
complex is formed, the GTPase activation step is insensitive to the
identity of the bound nucleotide.
In Fig. 3, we showed that XTP preferentially interacts with
mutant FtsY(D449N) over wild-type FtsY. The data in Fig. 4
complement these results by demonstrating that, reciprocally, GTP
preferentially interacts with wild-type FtsY over mutant
FtsY(D449N).
To provide independent evidence for the notion that complex
formation requires FtsY to be bound to its cognate nucleotide, we
directly monitored complex formation using a fluorescence assay
described previously (15, 29). The assay is based on the observation
that FtsY contains a tryptophan residue whose fluorescence prop-
erties change on binding SRP. In the course of the studies described
here, we observed that formation of this complex requires the
presence of Mg2 ions (Fig. 5A), which provided a convenient way
to initiate the reaction while keeping all other constituents in the
solution constant. In agreement with previous results, the fluores-
cence spectrum of wild-type FtsY exhibits a blue shift and an almost
2-fold increase in intensity on complex formation in the presence of
saturating GppNHp and Mg2 (Fig. 5A). In contrast, mutant
FtsY(D449N) showed no fluorescence change on addition of Mg2
when GppNHp was present as the sole nucleotide (Fig. 5B). When
the reaction is supplemented with XTP in addition to GppNHp,
however, the fluorescence increase is partially restored for mutant
FtsY(D449N) (Fig. 5D).
The smaller increase in fluorescence with mutant FtsY(D449N)
relative to that with wild-type FtsY is expected because the mutant
FtsY(D449N) binds XTP weakly, especially in the presence of
GppNHp. In addition, XTP can also bind to Ffh, and this binding
would inhibit complex formation by forcing a noncognate nucleo-
tide into SRP’s GTP-binding site [SRP binds XTP and GppNHp
with dissociation constants of 22 and 3.3 M, respectively (S.S. and
P.W., unpublished results)]. Therefore, at any given concentration
of GppNHp and XTP, only a fraction of proteins is occupied with
a cognate nucleotide, Ffh with GppNHp and FtsY(D449N) with
XTP. Indeed, addition of XTP into a reaction containing wild-type
FtsY and SRP reduces the fluorescence change on Mg2 addition
(Fig. 5C), demonstrating that the restoration of fluorescence in-
crease by XTP is specific for mutant FtsY(D449N) (Fig. 5D). Taken
together, the results of the fluorescence experiments provide
independent evidence that FtsY acquires the ability to discriminate
between cognate and noncognate nucleotides during formation of
the SRPFtsY complex.
Discussion
We have characterized here the nucleotide recognition proper-
ties of FtsY, one of the two directly interacting GTPases involved
in protein targeting. Our results further support the notion that
FtsY show many distinct features compared with the classical
‘‘GTPase switch’’ paradigm that has been described for other
GTPases (2). Thus, elucidation and comparison of the mecha-
nism of SRP subfamily of GTPases to those of other members
of the GTPase superfamily significantly broaden our view of the
basic principles of molecular recognition and regulation of
nucleotide-dependent molecular switches.
An Open, Nondiscriminating Nucleotide-Binding Site in Free FtsY.
GTPases are typically characterized by a high specificity for their
cognate guanine-containing nucleotides over noncognate nucleo-
tides. Unlike other GTPases, however, we show here that FtsY
Fig. 4. The SRP-stimulated GTPase reaction of wild-type FtsY (E) and mutant
FtsY(D449N) (F),determinedasdescribed inMaterialsandMethods. The linesare
fitsof theFtsYconcentrationdependences toasinglebindingcurveanalogous to
Eq. 1 and gave Km values of 0.77 and 8.2 M and maximal GTPase rate constants
(kcat) of 54 and 35 min1 for wild-type FtsY and mutant FtsY(D449N), respectively.
Fig. 5. Formation of the SRPFtsY complex requires FtsY to be bound with the
cognate nucleotide. The fluorescence emission spectrum of SRP mixed with
wild-type or mutant FtsY was determined in the presence of various nucleotides
with or without 10 mM added Mg2 (filled and open symbols, respectively), as
described in Materials and Methods. (A) Wild-type FtsY in the presence of 100M
GppNHp. (B) FtsY(D449N) in the presence of 100M GppNHp. (C) Wild-type FtsY
in the presence of 100 M GppNHp and 500 M XTP. (D) FtsY(D449N) in the
presence of 100M GppNHp and 500M XTP. In C and D, the dashed and dotted
lines are the spectra of FtsY (wild type or mutant) without added XTP in the
presence and absence of Mg2, respectively (data from A and B).
Shan and Walter PNAS  April 15, 2003  vol. 100  no. 8  4483
BI
O
CH
EM
IS
TR
Y
displays surprisingly low nucleotide specificity in its free, uncom-
plexed form.
The small difference in the nucleotide affinity and hydrolysis rate
between wild-type FtsY and mutant FtsY(D449N) shows that in
free FtsY the conserved Asp-449 does not form specific interactions
with the exocyclic amine of the guanine ring. Indeed, the weak GTP
affinity of FtsY and its ability to bind and hydrolyze a variety of
nucleotides suggest an open, floppy GTPase site that is prone to
rearrangements [Fig. 6, (FtsY)o]. Consistent with this model, the
crystal structure of FtsY in complex with GDP or GppNHp
revealed an elongated nucleotide-binding cleft in which the distance
between Asp-449 and the guanine ring appears to be too long to
make a strong hydrogen bond [D  4.6 and 3.4 Å] between the
carboxylic oxygen of Asp-449 and N2 of guanine in two different
crystal structures of FtsY bound with GppNHp from Thermus
aquaticus (C. Reyes, E. Rutenber, P.W., and R. Stroud, unpublished
results); in contrast, the corresponding distance is 2.9 Å in the Ras
structure (21) and 3.0 Å in the EF-Tu structure (18)]. Consistent
with this notion, the GTP-binding site also appeared wide open in
the crystal structure of apo-FtsY from E. coli (6).
Several previous studies also suggest the presence of a nonspe-
cific GTP-binding site in FtsY. Crosslinking and protease protec-
tion studies of E. coli FtsY suggested that GDP can interact with an
FtsY mutant, FtsY(D449A), at least as efficiently as wild-type FtsY
(30). The mammalian homolog of FtsY, SR, retains an affinity for
GTP within 2-fold of that of wild-type SR on mutation of the
conserved Asp (31). Thus, it appears that promiscuous nucleotide
recognition is a conserved property among bacterial FtsY and its
eukaryotic homologs. On the other hand, reduced interaction with
GTP and increased interaction with XTP on mutation of the Asp
have been reported in two cases (16, 32). Interestingly, the FtsY
construct used in one of these studies contains only the NG domain
of FtsY (16), raising the possibility that the A domain may play a
role in modulating the GTPase site of FtsY.
These structural and biochemical features of free FtsY are
distinct from those observed with many classical GTPases, for
which, in all structures examined to date, a network of hydrogen
bonding and salt bridge interactions within the nucleotide-binding
pocket provide a snug fit for GDP or GTP (18–21). This leads to
a large penalty in binding energy when modifications are made on
GTP or on active site residues to disrupt favorable interactions and
introduce unfavorable electrostatic andor steric interactions, as is
the case for the Asp3 Asn mutation and the guanine3 xanthine
base substitution. The snug binding of the guanine ring in classical
GTPases also leads to slow GDP dissociation, which becomes the
rate-limiting step in the functional cycles of these GTPases and thus
to the requirement for nucleotide exchange factors to convert from
their GDP- to GTP-bound forms. Thus, the floppy nucleotide-
binding pocket of FtsY rationalizes the absence of corresponding
nucleotide exchange factors for the SRP family of GTPases. The
open GTPase site of FtsY provides an alternative view to a
previously proposed model (16) in which the low affinity of FtsY for
nucleotides was attributed to a built-in exchange factor domain that,
as an added-on feature, actively stabilizes the nucleotide-free state
of FtsY.
Conformational Change on Complex Formation Between FtsY and SRP.
In contrast to the low nucleotide specificity in its free form, FtsY
acquires 103-fold enhanced specificity when it forms a complex with
SRP, allowing it to discriminate strongly between cognate and
noncognate nucleotides. Our data provide strong evidence that
during formation of the SRPFtsY complex, Asp-449 [or Asn-449 in
mutant FtsY(D449N)] forms specific hydrogen bonds with the
exocyclic amine of guanine (or the O2 of xanthine; Fig. 1). Thus,
significant conformational changes must occur in the GTP-binding
site of FtsY on complex formation.
The model in Fig. 6 accounts for the observed increase in the
nucleotide specificity of FtsY on binding SRP. We propose that
FtsY alters between two conformational states, an ‘‘open’’ and a
‘‘closed’’ state [Fig. 6, (FtsY)o and (FtsY)c, respectively]. In the open
state, the nucleotide-binding pocket is oversized, and thus interac-
tions of GTP with Asp-449 and possibly with other active site
residues are not formed. In this state, FtsY binds nucleotides weakly
and with little discrimination. In the ‘‘closed’’ state, GTP is more
precisely positioned in the GTPase site, forming specific interac-
tions with Asp-449 and possibly also with other catalytic residues at
the active site. Because free FtsY exhibits little discrimination
between guanine and xanthine and shows no effect of the D449N
mutation, it would exist predominantly in the open state (Fig. 6, K	
 1). On complex formation with SRP, FtsY displays nucleotide
recognition properties expected for the closed state (Fig. 6, K	

1). Thus, SRP must bind preferentially to the population of FtsY
molecules that are in the closed state (Fig. 6, Kb,closed 
 Kb,open),
thereby driving the open 3 closed conformational change.
A large body of data supports the presence of a conformational
change on FtsY during complex formation. Conformational
changes in the GTPase sites of FtsY and Ffh have been proposed
based on biochemical data that suggest that active site contacts with
the -phosphate of GTP are formed only in the SRPFtsY complex
but not in the free proteins (26). In addition, proteolysis studies
suggested conformational changes in the N domain of FtsY (33),
and site-directed mutagenesis provided evidence for conforma-
tional rearrangements at the NG interface of Ffh and FtsY (34). It
remains to be determined whether the previous results and the data
presented herein report on the same or different conformational
rearrangements that occur during complex formation.
In contrast to FtsY, its binding partner Ffh has a high specificity
for GTP over noncognate nucleotides, and this GTP specificity is
switched 104-fold to that for XTP by mutation of the corresponding
Asp residue to Asn (S.S. and P.W., unpublished results). Consistent
Fig. 6. Model for SRP-induced conformational change of FtsY. (FtsY)o and
(FtsY)c denote the open and closed states of FtsY, respectively. K	 and K	are
the equilibrium constants for the open 3 closed conformational change with
free FtsY and FtsY bound to SRP, respectively, and Kb,open and Kb,closed denote the
equilibrium for SRP binding in the open and closed states, respectively. R denotes
the ribose ring, P denotes the phosphate groups, and the waves depict the floppy
binding and inaccurate positioning of GTP within the nucleotide-binding site in
the open state. The dashed lines depict the hydrogen bonding interaction be-
tween Asp-449 and N2 of guanine and possible additional interactions formed
between active site residues and GTP in the closed conformation.
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with the biochemical data, the crystal structure of Ffh revealed that
the conserved Asp is positioned close to the N2 of guanine ring to
make a good hydrogen bond (35). Thus, if the principles of our
model also apply to Ffh, then Ffh and FtsY lie on different points
of equilibrium for the open 3 closed conformational change. In
this respect, therefore, Ffh and FtsY do not behave in a perfectly
symmetric fashion as was previously thought.
Once the SRPFtsY complex is formed, Ffh and FtsY act as
GTPase activating proteins (GAPs) for one another, resulting in
reciprocal stimulation of GTP hydrolysis. One possible mechanism
for this activation is that Ffh inserts a missing catalytic residue(s)
into the GTPase active site of FtsY (and vice versa), as proposed
for the mechanism of action of GAPs for Ras and other classical G
proteins (21, 36–42). Alternatively, the stimulation of GTPase
activity could arise from conformational changes, whereas the
essential catalytic groups are provided by the GTPase itself. The
increased nucleotide specificity in FtsY shown here suggests that
additional interactions between the nucleotide and active site
residues are formed on complex formation. We suggest that these
additional binding interactions can lead to better positioning of the
-phosphate group with respect to catalytic residues in FtsY. This
would reduce the rearrangements that need to occur in going from
the ground state to the reaction’s transition state, thereby effecting
an acceleration of the GTP hydrolysis reaction (43). Thus, FtsY
may use a mechanism for GTPase activation that is distinct from
those discussed for other GTPases interacting with their respective
GAPs. In the most extreme form of this model, these conforma-
tional changes account for all of the observed GAP activity without
insertion of a catalytic residue from GAP. In principle, however,
GAP activity could result from a combination of these effects.
The ‘‘open’’ state of FtsY defined here explains previous obser-
vations that FtsY (or its mammalian homolog, SR) is in an ‘‘empty
site’’ form before its interaction with SRP (31). This notion was
based on the observation that, in contrast to the SRP–SR complex,
GTP could not be copurified with SR, and GppNHp prebound to
SR rapidly exchanges with GTP and GDP (31). Thus a model was
proposed in which FtsY would be in a nucleotide-free state before
interaction with SRP. However, the concept of a nucleotide-free
state for FtsY before binding SRP is difficult to reconcile with
affinity measurements of free FtsY for GTP and GDP (Kd 15 and
30 M, respectively; Table 2). On the basis of these affinities, free
FtsY should always be saturated with GTP at physiological con-
centrations of GTP and GDP (900 and 100 M, respectively; ref.
44) even before SRP binding. We propose that the previous
observations can be better explained by the ‘‘open’’ state of FtsY,
in which the nucleotide is bound but not well enough positioned and
thus exchanges rapidly with the solution (koff  15 s1; ref. 15).
Biological Implications. The switch of FtsY from the ‘‘open’’ to the
‘‘closed’’ conformation provides an attractive point of regulation
by additional components of the protein targeting reaction. As
shown here, free FtsY exists predominantly in the ‘‘open’’ state
in which it is less active in interacting with SRP or in binding and
hydrolyzing GTP. Thus, any factor that shifts the conformational
equilibrium of FtsY toward the ‘‘closed’’ state would facilitate its
interaction with SRP. Phospholipids in the membrane andor
the translocon, for example, are potential candidates to play such
a regulatory role. In this way, FtsY molecules bound to the
membrane and in the vicinity of available protein translocation
sites would be selectively predisposed to interact with SRP.
Reciprocally, the GTPase domain of Ffh might be similarly
controlled, possibly involving other rearrangements in the active
site that are less apparent as a gain in nucleotide specificity. For
Ffh, potential regulators would include the ribosome and signal
sequence. In this way, both SRP and FtsY would each be
‘‘primed’’ on interaction with their respective cargo molecules, so
that the resulting SRP–FtsY interaction can efficiently deliver
the nascent polypeptide chains to the translocation machinery.
This model also explains why the substantial fraction of free
FtsY normally present in the cytosol (45) does not lead to futile
cycles of GTP hydrolysis or nascent chain release from SRP.
Thus, the SRP–FtsY interaction, which functions at the very
heart of SRP-dependent protein targeting, would be regulated
not only by occupancy of either binding partner with nucleotide
triphosphate per se but also by conformational switches that are
controlled by their respective cargo molecules.
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